Plasma-lyte 148: Clinical Trials

12 trials of Plasma-lyte 148, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 3 unknown, 1 active not recruiting, 1 terminated. 5 Phase 3, 3 Phase 4, 1 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Completed 5
Phase 43Completed 1, Terminated 1, Unknown 1
Not applicable1Completed 1
Phase 11Active not recruiting 1
Phase 21Active not recruiting 1

Follow Plasma-lyte 148: new trials by email Literature Review of Plasma-lyte 148 trials Research Report on Plasma-lyte 148

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosis
Plasma-Lyte 148, 0.9% sodium chloride - Diabetic Ketoacidosis
Phase 3CompletedThe George Institute5472024-03-142026-10-05
Goal-directed Fluid Therapy During Deep Inferior Epigastric Perforator (DIEP) Free Flap Breast Reconstruction
Plasma-lyte (static group), Norepinephrine (static group), Plasma-lyte (dynamic group) - Hypotension During Surgery
Phase 4TerminatedAlgemeen Ziekenhuis Maria Middelares412023-11-232026-10-28
Using Vasopressor Medication to Support Blood Pressure During Intubation Procedure
Norepinephrine, Lactated Ringers, Intravenous, normal saline - Respiratory Failure, Hypotension and Shock
Phase 3CompletedWright State University422022-08-092024-07-15
Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis
Lactated Ringer, Normal Saline, Plasma-lyte - Shock, Septic
Phase 3CompletedChildren's Hospital of Philadelphia90412020-08-252026-03-05
Balanced Crystalloids in Postpartum Hemorrhage
Lactate Ringer, Plasma-lyte - Postpartum Hemorrhage
UnknownFundación Santa Fe de Bogota402019-01-252019-02-04
Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST)
Human umbilical cord derived CD362 enriched MSCs, Placebo (Plasma-Lyte 148) - Acute Respiratory Distress Syndrome
Phase 1 / Phase 2Active not recruitingBelfast Health and Social Care Trust1292019-01-072025-09-08
Better Evidence for Selecting Transplant Fluids
Plasma-Lyte 148 (approx. pH 7.4) IV Infusion, 0.9% SODIUM CHLORIDE 9g/L injection BP - End Stage Kidney Disease, Delayed Graft Function
Phase 3CompletedThe University of Queensland8082018-01-262024-10-15
Plasma-Lyte 148® versUs Saline Study
Plasma-Lyte 148®, 0.9% sodium chloride - Hypovolemia
Phase 4CompletedThe George Institute50372017-09-012023-08-08
Balanced Solution Versus Saline in Intensive Care Study
Plasma-Lyte, Saline 0.9%, Slow infusion speed - Critical Illness, Acute Kidney Injury
Phase 3CompletedHospital do Coracao110752017-05-272021-04-19
Normal Saline Vrs Balanced i.v. Fluids in Neurosurgery
Normal saline, Balanced fluid - Benign Neoplasms, Vascular Malformations, Brain
UnknownClinical Hospital Centre Zagreb1202017-03-232019-04-18
Decision Support for Intraoperative Low Blood Pressure
Attending real-time decision support, In-room real-time decision support, Attending feedback emails - Hypotension
Not applicableCompletedVanderbilt University Medical Center224352017-01-052019-05-16
0,9% NaCl Effect on Kidney Function and Glycocalyx in Patients Operated on for Primary Hiparthrosis
Plasma-lyte, 0,9% saline - Nephrotoxicity
Phase 4UnknownRegional Hospital Holstebro402015-03-012015-08-19

Conditions studied

Hypotension (3)  ·  Acute Kidney Injury (2)  ·  Critical Illness (2)  ·  Shock (2)  ·  COVID-19 (1)  ·  Central Nervous System Vascular Malformations (1)  ·  Delayed Graft Function (1)  ·  Diabetic Ketoacidosis (1)  ·  Hypovolemia (1)  ·  Kidney Failure, Chronic (1)  ·  Neoplasms (1)  ·  Postpartum Hemorrhage (1)  ·  Respiratory Distress Syndrome (1)  ·  Respiratory Insufficiency (1)  ·  Sepsis (1)

Sponsors

The George Institute (2)  ·  Algemeen Ziekenhuis Maria Middelares (1)  ·  Belfast Health and Social Care Trust (1)  ·  Children's Hospital of Philadelphia (1)  ·  Clinical Hospital Centre Zagreb (1)  ·  Fundación Santa Fe de Bogota (1)  ·  Hospital do Coracao (1)  ·  Regional Hospital Holstebro (1)  ·  The University of Queensland (1)  ·  Vanderbilt University Medical Center (1)  ·  Wright State University (1)

Countries

Australia (3)  ·  United States (3)  ·  New Zealand (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Colombia (1)  ·  Croatia (1)  ·  Denmark (1)  ·  United Kingdom (1)

Top investigators

Alexandre B Cavalcanti, MD, PhD (1)  ·  Danny F McAuley, Professor (1)  ·  Erling B Perdersen, MD, DMSc (1)  ·  Fernando G Zampieri, MD (1)  ·  Fran Balamuth, MD PhD MSCE (1)  ·  Jesper N Bech, MD, PhD (1)  ·  Jonathan P Wanderer, MD, MPhil (1)  ·  Leopoldo E Ferrer, M.D. (1)  ·  Matthew Koroscil, MD (1)  ·  Michael Collins, MBChB,FRACP,PhD (1)  ·  Natasa Kovac, M.D. (1)  ·  Nilton Brandao, MD, PhD (1)

Results publications

PMID 28651514, PMID 32450917, PMID 32493473, PMID 33771116, PMID 34375394, PMID 34547081, PMID 34742327, PMID 34746723, PMID 35041780, PMID 35042554, PMID 35349397, PMID 35562778, PMID 35843046, PMID 36735931, PMID 36888820, PMID 37154608, PMID 37343576, PMID 42028918

NIH funding

R01HD101528 (1)